Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Clinical and functional outcomes of primary total knee arthroplasty: a South American perspective.

Figueroa D, Calvo R, Figueroa F, Avilés C, Garín A, Cancino J.

Arthroplast Today. 2019 Aug 23;5(3):358-361. doi: 10.1016/j.artd.2019.04.012. eCollection 2019 Sep.

2.

Myoclonic status epilepticus induced by cefepime overdose requiring haemodialysis.

Garin A, Bavozet F.

BMJ Case Rep. 2019 Jun 6;12(6). pii: e228108. doi: 10.1136/bcr-2018-228108.

PMID:
31175111
3.

Total knee replacement in patients with osteoarthritis and concomitant inveterate patellar dislocation.

Figueroa D, Garín A, Figueroa F.

Arthroplast Today. 2018 May 28;5(1):68-72. doi: 10.1016/j.artd.2018.04.003. eCollection 2019 Mar.

4.

Nasal response to stress test in healthy subjects: an experimental pilot study.

De Kermadec H, Bequignon E, Zerah-Lancner F, Garin A, Devars du Mayne M, Coste A, Louis B, Papon JF.

Eur Arch Otorhinolaryngol. 2019 May;276(5):1391-1396. doi: 10.1007/s00405-019-05343-6. Epub 2019 Feb 15.

PMID:
30771060
5.

Metropolitan W135 meningococcal compressive pericarditis treated with intrapericardial fibrinolysis.

Garin A, Bavozet F.

BMJ Case Rep. 2018 Oct 16;2018. pii: bcr-2018-225080. doi: 10.1136/bcr-2018-225080.

PMID:
30333198
6.

[Techniques and progress in the imaging of the ear].

Garin A, Benoudiba F, Ducreux D.

Presse Med. 2017 Nov;46(11):1097-1105. doi: 10.1016/j.lpm.2017.09.017. Epub 2017 Oct 31. French.

PMID:
29097036
7.

X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3.

Olcese C, Patel MP, Shoemark A, Kiviluoto S, Legendre M, Williams HJ, Vaughan CK, Hayward J, Goldenberg A, Emes RD, Munye MM, Dyer L, Cahill T, Bevillard J, Gehrig C, Guipponi M, Chantot S, Duquesnoy P, Thomas L, Jeanson L, Copin B, Tamalet A, Thauvin-Robinet C, Papon JF, Garin A, Pin I, Vera G, Aurora P, Fassad MR, Jenkins L, Boustred C, Cullup T, Dixon M, Onoufriadis A, Bush A, Chung EM, Antonarakis SE, Loebinger MR, Wilson R, Armengot M, Escudier E, Hogg C; UK10K Rare Group, Amselem S, Sun Z, Bartoloni L, Blouin JL, Mitchison HM.

Nat Commun. 2017 Feb 8;8:14279. doi: 10.1038/ncomms14279.

8.

Nuclear Protein of the Testis Midline Carcinoma Masquerading as a Primary Mediastinal Seminoma.

Sayapina MS, Savelov NA, Karseladze AI, Bulanov AA, Tryakin AA, Nosov DA, Garin AM, Tjulandin SA.

Rare Tumors. 2016 Jun 28;8(2):6241. doi: 10.4081/rt.2016.6241. eCollection 2016 Jun 28.

9.

Pediatric sinogenic epidural and subdural empyema: The role of endoscopic sinus surgery.

Garin A, Thierry B, Leboulanger N, Blauwblomme T, Grevent D, Blanot S, Garabedian N, Couloigner V.

Int J Pediatr Otorhinolaryngol. 2015 Oct;79(10):1752-60. doi: 10.1016/j.ijporl.2015.08.007. Epub 2015 Aug 13.

PMID:
26304070
10.

Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.

Fedyanin M, Tryakin A, Bulanov A, Vybarava A, Tjulandina A, Chekini D, Sekhina O, Figurin K, Garin A, Tjulandin S.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1259-64. doi: 10.1007/s00432-015-1914-5. Epub 2015 Jan 14.

PMID:
25586890
11.

Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.

Fedyanin M, Tryakin A, Mosyakova Y, Pokataev I, Bulanov A, Zakharova T, Polockii B, Garin A, Tjulandin S.

J Cancer Res Clin Oncol. 2014 Feb;140(2):311-8. doi: 10.1007/s00432-013-1567-1. Epub 2013 Dec 17.

PMID:
24337455
12.

Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivity.

Poplin E, Wasan H, Rolfe L, Raponi M, Ikdahl T, Bondarenko I, Davidenko I, Bondar V, Garin A, Boeck S, Ormanns S, Heinemann V, Bassi C, Evans TR, Andersson R, Hahn H, Picozzi V, Dicker A, Mann E, Voong C, Kaur P, Isaacson J, Allen A.

J Clin Oncol. 2013 Dec 10;31(35):4453-61. doi: 10.1200/JCO.2013.51.0826. Epub 2013 Nov 12.

PMID:
24220555
13.

The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans.

Krohn S, Garin A, Gabay C, Proudfoot AE.

Front Immunol. 2013 Jul 15;4:193. doi: 10.3389/fimmu.2013.00193. eCollection 2013.

14.

Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN).

David S, Marchais H, Hervé-Aubert K, Bedin D, Garin AS, Hoinard C, Chourpa I.

Int J Pharm. 2013 Oct 1;454(2):660-7. doi: 10.1016/j.ijpharm.2013.05.051. Epub 2013 May 31.

PMID:
23726903
15.

Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis.

Fedyanin M, Tryakin A, Bulanov A, Fainshtein I, Zakharova T, Matveev V, Garin A, Tjulandin S.

Urol Oncol. 2014 Jan;32(1):32.e27-33. doi: 10.1016/j.urolonc.2012.12.001. Epub 2013 Apr 28.

PMID:
23628310
16.

Chemokine receptor antagonist development.

Garin A, Johnson Z, Hermant A, Beltran F, Ratinaud Y, Michel A, Krohn S, Gaudet M, Carboni S, Ji H, Missotten M, Leger O, Power C, Proudfoot A.

Methods Mol Biol. 2013;1013:67-92. doi: 10.1007/978-1-62703-426-5_6.

PMID:
23625494
17.

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.

Wolff AC, Lazar AA, Bondarenko I, Garin AM, Brincat S, Chow L, Sun Y, Neskovic-Konstantinovic Z, Guimaraes RC, Fumoleau P, Chan A, Hachemi S, Strahs A, Cincotta M, Berkenblit A, Krygowski M, Kang LL, Moore L, Hayes DF.

J Clin Oncol. 2013 Jan 10;31(2):195-202. doi: 10.1200/JCO.2011.38.3331. Epub 2012 Dec 10.

18.

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A.

Ann Oncol. 2012 Oct;23(10):2479-516.

PMID:
23012255
19.

[Evolution and revolutionary events in oncology in the end of XX - beginning of XXI century].

Garin AM.

Vestn Ross Akad Med Nauk. 2012;(3):32-6. Review. Russian.

PMID:
22712272
20.

Current status of chemokine receptor inhibitors in development.

Allegretti M, Cesta MC, Garin A, Proudfoot AE.

Immunol Lett. 2012 Jul 30;145(1-2):68-78. doi: 10.1016/j.imlet.2012.04.003. Epub 2012 Apr 20. Review.

PMID:
22698186
21.

Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.

de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L.

J Clin Oncol. 2012 Mar 10;30(8):792-9. doi: 10.1200/JCO.2011.37.0171. Epub 2012 Jan 23.

22.

An international multicenter randomized controlled trial of G17DT in patients with pancreatic cancer.

Gilliam AD, Broome P, Topuzov EG, Garin AM, Pulay I, Humphreys J, Whitehead A, Takhar A, Rowlands BJ, Beckingham IJ.

Pancreas. 2012 Apr;41(3):374-9. doi: 10.1097/MPA.0b013e31822ade7e.

PMID:
22228104
23.

Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer.

Buzdar A, Vogel C, Schwartzberg L, Garin A, Perez A, Ingle J, Houghton M, Zergebel C, Kimball B.

Cancer. 2012 Jul 1;118(13):3244-53. doi: 10.1002/cncr.26419. Epub 2011 Nov 1.

24.

Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.

Fedyanin M, Tryakin A, Kanagavel D, Bulanov A, Burova A, Figurin K, Fainshtein I, Sergeev U, Zakharova T, Garin A, Tjulandin S.

Urol Oncol. 2013 May;31(4):499-504. doi: 10.1016/j.urolonc.2011.06.001. Epub 2011 Jul 30.

PMID:
21803619
25.

Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.

Tryakin A, Fedyanin M, Kanagavel D, Fainstein I, Sergeev J, Polockij B, Matveev V, Zakharova T, Garin A, Tjulandin S.

Urology. 2011 Sep;78(3):620-5. doi: 10.1016/j.urology.2011.05.005. Epub 2011 Jul 20.

PMID:
21764427
26.

Chemokines as targets for therapy.

Garin A, Proudfoot AE.

Exp Cell Res. 2011 Mar 10;317(5):602-12. doi: 10.1016/j.yexcr.2010.12.021. Review. No abstract available.

PMID:
21376173
27.

Toll-like receptor 4 signaling by follicular dendritic cells is pivotal for germinal center onset and affinity maturation.

Garin A, Meyer-Hermann M, Contie M, Figge MT, Buatois V, Gunzer M, Toellner KM, Elson G, Kosco-Vilbois MH.

Immunity. 2010 Jul 23;33(1):84-95. doi: 10.1016/j.immuni.2010.07.005.

28.

Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, Vynnychenko I, Garin A, Lang I, Falcon S.

J Clin Oncol. 2010 Mar 20;28(9):1547-53. doi: 10.1200/JCO.2009.25.4706. Epub 2010 Feb 16.

PMID:
20159816
29.

A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.

Kanagavel D, Pokataev IA, Fedyanin MY, Tryakin AA, Bazin IS, Narimanov MN, Yakovleva ES, Garin AM, Tjulandin SA.

Ann Oncol. 2010 Sep;21(9):1779-85. doi: 10.1093/annonc/mdq032. Epub 2010 Feb 11.

PMID:
20150573
30.

[Final results of cooperative studies of dicarbamine used as a hemoprotector in combination chemotherapy for cancer].

Bychkov MB, Besova NS, Topchieva SV, Verebnikova NV, Gorbunova VA, Garin AM, Chitiia LV, Borisov VI, Gurov SN, Gershanovich ML, Filatova LV, Makhnova EV, Raĭkhlin NT, Treshchalina EM, Sitdikova SM, Nebol'sin VE.

Vopr Onkol. 2009;55(5):627-33. Russian. No abstract available.

PMID:
20020662
31.

[Targeted drugs for the treatment of disseminated colonic cancer].

Garin AM, Bazin IS, Kanagavel D.

Vestn Ross Akad Med Nauk. 2009;(8):17-20. Review. Russian.

PMID:
19802936
32.

[Docetaxel in the treatment of metastatic gastric cancer].

Bazin IS, Kanagavel D, Nasyrova RIu, Garin AM, Tiuliandin SA.

Vestn Ross Akad Med Nauk. 2009;(8):26-8. Review. Russian.

PMID:
19799210
33.

Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].

Stewart JS, Cohen EE, Licitra L, Van Herpen CM, Khorprasert C, Soulieres D, Vodvarka P, Rischin D, Garin AM, Hirsch FR, Varella-Garcia M, Ghiorghiu S, Hargreaves L, Armour A, Speake G, Swaisland A, Vokes EE.

J Clin Oncol. 2009 Apr 10;27(11):1864-71. doi: 10.1200/JCO.2008.17.0530. Epub 2009 Mar 16. Erratum in: J Clin Oncol. 2009 Jul 10;27(20):3410.

PMID:
19289630
34.

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.

Ciuleanu TE, Pavlovsky AV, Bodoky G, Garin AM, Langmuir VK, Kroll S, Tidmarsh GT.

Eur J Cancer. 2009 Jun;45(9):1589-96. doi: 10.1016/j.ejca.2008.12.022. Epub 2009 Jan 31.

PMID:
19188061
35.

Deriving a germinal center lymphocyte migration model from two-photon data.

Figge MT, Garin A, Gunzer M, Kosco-Vilbois M, Toellner KM, Meyer-Hermann M.

J Exp Med. 2008 Dec 22;205(13):3019-29. doi: 10.1084/jem.20081160. Epub 2008 Dec 1.

36.

3D and 4D imaging of immune cells in vitro and in vivo.

Nitschke C, Garin A, Kosco-Vilbois M, Gunzer M.

Histochem Cell Biol. 2008 Dec;130(6):1053-62. doi: 10.1007/s00418-008-0520-x. Epub 2008 Oct 15. Review.

PMID:
18855003
37.

The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.

Ledgerwood LG, Lal G, Zhang N, Garin A, Esses SJ, Ginhoux F, Merad M, Peche H, Lira SA, Ding Y, Yang Y, He X, Schuchman EH, Allende ML, Ochando JC, Bromberg JS.

Nat Immunol. 2008 Jan;9(1):42-53. Epub 2007 Nov 25.

PMID:
18037890
38.

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer.

Garin A, Manikhas A, Biakhov M, Chezhin M, Ivanchenko T, Krejcy K, Karaseva V, Tjulandin S.

Breast Cancer Res Treat. 2008 Jul;110(2):309-15. Epub 2007 Sep 13.

PMID:
17851759
39.

Effect of different thermal conditions on the pre-imaginal biology of Culex apicinus (Philippi, 1865) (Diptera: Culicidae).

Loetti MV, Burroni NE, Schweigmann N, de Garin A.

J Vector Ecol. 2007 Jun;32(1):106-11.

PMID:
17639632
40.

A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.

Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.

J Infect Dis. 2007 May 1;195(9):1332-9. Epub 2007 Mar 19.

PMID:
17397004
41.

The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin.

Martin AP, Alexander-Brett JM, Canasto-Chibuque C, Garin A, Bromberg JS, Fremont DH, Lira SA.

J Immunol. 2007 Apr 1;178(7):4623-31.

42.

Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid.

Furtado GC, Marinkovic T, Martin AP, Garin A, Hoch B, Hubner W, Chen BK, Genden E, Skobe M, Lira SA.

Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5026-31. Epub 2007 Mar 14.

43.

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ.

J Clin Invest. 2007 Jan;117(1):185-94.

44.

Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Marinkovic T, Garin A, Yokota Y, Fu YX, Ruddle NH, Furtado GC, Lira SA.

J Clin Invest. 2006 Oct;116(10):2622-32. Epub 2006 Sep 21.

45.

Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts.

Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, Jessberger R, Trinchieri G, Lira SA, Randolph GJ, Bromberg JS.

Nat Immunol. 2006 Jun;7(6):652-62. Epub 2006 Apr 23.

PMID:
16633346
46.

The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells.

Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC, Lira SA.

J Clin Invest. 2006 May;116(5):1264-73. Epub 2006 Apr 6.

47.

CD4+ CD25+ regulatory T-cells inhibit the islet innate immune response and promote islet engraftment.

Chen D, Zhang N, Fu S, Schröppel B, Guo Q, Garin A, Lira SA, Bromberg JS.

Diabetes. 2006 Apr;55(4):1011-21.

48.

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.

Karthaus M, Kretzschmar A, Kröning H, Biakhov M, Irwin D, Marschner N, Slabber C, Fountzilas G, Garin A, Abecasis NG, Baronius W, Steger GG, Südhoff T, Giorgetti C, Reichardt P.

Ann Oncol. 2006 Feb;17(2):289-96. Epub 2005 Nov 29.

PMID:
16317012
49.

Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

Ochando JC, Yopp AC, Yang Y, Garin A, Li Y, Boros P, Llodra J, Ding Y, Lira SA, Krieger NR, Bromberg JS.

J Immunol. 2005 Jun 1;174(11):6993-7005.

50.

Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes.

Qu C, Edwards EW, Tacke F, Angeli V, Llodrá J, Sanchez-Schmitz G, Garin A, Haque NS, Peters W, van Rooijen N, Sanchez-Torres C, Bromberg J, Charo IF, Jung S, Lira SA, Randolph GJ.

J Exp Med. 2004 Nov 15;200(10):1231-41. Epub 2004 Nov 8.

Supplemental Content

Support Center